Patient Blood Management: transfusion appropriateness in the post-operative period.


Journal

Blood transfusion = Trasfusione del sangue
ISSN: 2385-2070
Titre abrégé: Blood Transfus
Pays: Italy
ID NLM: 101237479

Informations de publication

Date de publication:
11 2019
Historique:
received: 12 02 2019
accepted: 15 05 2019
pubmed: 14 8 2019
medline: 8 5 2020
entrez: 13 8 2019
Statut: ppublish

Résumé

Within the context of Patient Blood Management (PBM) policy for the peri-operative period, the transfusion medicine unit of our institution adopted a series of strategies to support and enhance red blood cell (RBC) transfusion best practices. This study aimed to evaluate the appropriateness of RBC transfusion therapy in the post-operative period, before and after starting a multifactorial PBM policy. A 2-phase observational study was conducted on patients who underwent major surgery. The study was designed as follows: 3 months of preliminary audit, followed by multifactorial PBM policy, and a final audit. The policy comprised seminars, teaching lessons, periodic consultations and the insertion of Points of Care. RBC transfusion appropriateness was evaluated in both audits. The preliminary audit, performed on 168 patients, showed that 37.7% of the patients were appropriately transfused. The final audit, performed on 205 patients, indicated a significant increase of RBC transfusion appropriateness to 65.4%. In our experience, our multifactorial PBM policy improved the RBC transfusion appropriateness in the post-operative period. We believe that our multifactorial PBM policy, which comprises the insertion of Points of Care, supported the healthcare workers in the transfusion decision-making process. This enhancement of transfusion appropriateness implies clinical and managerial advantages, such as reduced transfusion-related risks, optimisation of health care resources, and reduction in costs.

Sections du résumé

BACKGROUND
Within the context of Patient Blood Management (PBM) policy for the peri-operative period, the transfusion medicine unit of our institution adopted a series of strategies to support and enhance red blood cell (RBC) transfusion best practices. This study aimed to evaluate the appropriateness of RBC transfusion therapy in the post-operative period, before and after starting a multifactorial PBM policy.
MATERIALS AND METHODS
A 2-phase observational study was conducted on patients who underwent major surgery. The study was designed as follows: 3 months of preliminary audit, followed by multifactorial PBM policy, and a final audit. The policy comprised seminars, teaching lessons, periodic consultations and the insertion of Points of Care. RBC transfusion appropriateness was evaluated in both audits.
RESULTS
The preliminary audit, performed on 168 patients, showed that 37.7% of the patients were appropriately transfused. The final audit, performed on 205 patients, indicated a significant increase of RBC transfusion appropriateness to 65.4%.
DISCUSSION
In our experience, our multifactorial PBM policy improved the RBC transfusion appropriateness in the post-operative period. We believe that our multifactorial PBM policy, which comprises the insertion of Points of Care, supported the healthcare workers in the transfusion decision-making process. This enhancement of transfusion appropriateness implies clinical and managerial advantages, such as reduced transfusion-related risks, optimisation of health care resources, and reduction in costs.

Identifiants

pubmed: 31403929
pii: 2019.0035-19
doi: 10.2450/2019.0035-19
pmc: PMC6917537
doi:

Types de publication

Clinical Trial, Phase II Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

459-464

Références

Br J Anaesth. 2016 Nov;117(5):610-616
pubmed: 27799175
Crit Care. 2017 Dec 28;21(Suppl 3):310
pubmed: 29297368
Br J Surg. 1998 Jan;85(1):41-5
pubmed: 9462381
Best Pract Res Clin Anaesthesiol. 2012 Dec;26(4):475-84
pubmed: 23351234
JAMA. 2016 Nov 15;316(19):2025-2035
pubmed: 27732721
Eur J Intern Med. 2004 Dec;15(8):481-486
pubmed: 15668082
Blood Transfus. 2011 Apr;9(2):189-217
pubmed: 21527082
Transfus Med Rev. 2017 Jan;31(1):62-71
pubmed: 27317382
J Clin Monit Comput. 2015 Dec;29(6):733-40
pubmed: 25649717
Blood Transfus. 2011 Jan;9(1):19-40
pubmed: 21235852
Blood Transfus. 2013 Apr;11(2):193-202
pubmed: 23399354
Int J Lab Hematol. 2008 Apr;30(2):105-16
pubmed: 18333842
Best Pract Res Clin Anaesthesiol. 2013 Mar;27(1):37-42
pubmed: 23590914
Blood Transfus. 2014 Oct;12(4):548-56
pubmed: 24960643
Eur J Anaesthesiol. 2013 Jun;30(6):270-382
pubmed: 23656742
Blood Transfus. 2011 Jul;9(3):320-35
pubmed: 21627922
Best Pract Res Clin Anaesthesiol. 2008 Sep;22(3):503-17
pubmed: 18831300
Blood Rev. 2003 Dec;17(4):195-208
pubmed: 14556774
Best Pract Res Clin Anaesthesiol. 2013 Mar;27(1):17-35
pubmed: 23590913
Blood Transfus. 2017 Jul;15(4):325-328
pubmed: 28488975

Auteurs

Erminia Di Bartolomeo (E)

Transfusion Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.

Lucia Merolle (L)

Transfusion Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.

Chiara Marraccini (C)

Transfusion Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.

Laura Canovi (L)

Transfusion Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.

Pamela Berni (P)

Transfusion Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.

Monica Guberti (M)

Health Care Professionals Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.

Angela Mazzi (A)

Transfusion Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.

Alessandro Bonini (A)

Transfusion Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.

Nicola Romano (N)

Transfusion Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.

Antonia Magnani (A)

Operations Management Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.

Thelma Aguiar Pertinhez (TA)

Transfusion Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
Department of Medicine and Surgery, University of Parma, Parma, Italy.

Roberto Baricchi (R)

Transfusion Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH